[18F]LSN3316612

DIAGNOSTIC_TEST2 trials

Sponsors

Eli Lilly and Company

Conditions

Healthy

Phase 1

A Study of the Effects of LY3372689 on the Brain in Healthy Participants

CompletedNCT03944031

Eli Lilly and CompanyHealthy

Start: 2019-05-08End: 2020-02-19Updated: 2020-04-22

A Study of the Effects of Multiple Doses of LY3372689 on the Brain in Healthy Participants

CompletedNCT04392271

Eli Lilly and CompanyHealthy

Start: 2020-08-06End: 2020-10-14Updated: 2020-11-04

Related Papers

Brain target occupancy of LY3372689, an inhibitor of the O‐GlcNAcase (OGA) enzyme, following administration of single and multiple doses to healthy volunteers

Alzheimer s & Dementia2021-12-018 citations

Brain target occupancy of LY3372689, an inhibitor of the O‐GlcNAcase (OGA) enzyme: Translation from rat to human

Alzheimer s & Dementia2020-12-0119 citations